Scientists have already discovered that the gut microbiome is altered in people with chronic heart disease. They subsequently identified compounds that are produced by the diseased microbiome, for instance a bacterial compound called trimethylamine (TMA) that after modification in the liver of the human host causes arteriosclerosis.
News | Heart Failure
Scientists Characterize the Imbalanced Gut Bacteria of Patients with Myocardial Infarction, Angina and Heart Failure
February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may have ...
Home February 21, 2022
Home
Researchers at Gladstone; Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.
News | Congenital Heart
Getting to the Heart of Complex Disease
February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life ...
Home February 21, 2022
Home
Angioscopic findings in the FPA and infrapopliteal lesions
News | Peripheral Artery Disease (PAD)
Study Finds Ulcerated Plaque in the Femoropopliteal Artery as Source of Arterial Embolism in the Popliteal Arteries
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of ...
Home February 21, 2022
Home
An ultrasound is taken of a patient's heart.
News | Cardiac Imaging
A Non-invasive Way to Predict Heart Attack and Stroke
February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and ...
Home February 21, 2022
Home
Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening heart failure through its randomized controlled trial, Ultrafiltration Versus IV Diuretics in Worsening Heart Failure, the REVERSE-HF Study.
News | Heart Failure
Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of ...

Home February 21, 2022
Home
Pipeline for creating synthetic images and validation process.
News | Cardiac Imaging
New Tool for 3-D Measurement of the Aorta May Identify Fatal Heart Conditions Earlier
February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s largest ...
Home February 21, 2022
Home
Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 
News | Cardiovascular Surgery
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
Daxor’s Blood Volume (BVA-100) Diagnostic
News | Heart Failure
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure
February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data ...
Home February 18, 2022
Home
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
News | Endovascular Aortic Repair
Front Line Medical Technologies Expands Availability of its COBRA-OS

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
Already used in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for adult patients, Rapiscan is now approved for use in stress cardiac magnetic resonance imaging (CMR)
News | Cardiac Imaging
GE Healthcare’s Stress Agent Rapiscan Approved for use in Stress Cardiac Magnetic Resonance Imaging

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) ...

Home February 18, 2022
Home
Clinical Case of the Month
News | Cardiovascular Clinical Studies
Call for Entries!

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...

Home February 17, 2022
Home
Myocarditis (inflammation of the heart muscle) after vaccination is rare, but some cases have been reported after receipt of the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccine.
News | Coronavirus (COVID-19)
COVID Vax–related Myocarditis May be Milder Than That of Other Causes

February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as ...

Home February 17, 2022
Home
Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is leveraging its capabilities in the cardiology space with its new Cloud for Cardiology.
News | Cardiovascular Education
Mytonomy Announces Cardiology Content and Platform

February 17, 2022 – Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is ...

Home February 17, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Heart Failure | By Melinda Taschetta-Millane
Pig Heart Transplant Patient Continues to Thrive

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) ...

Home February 16, 2022
Home
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System,
News | Stents Drug Eluting
Elixir Medical Completes Enrollment in Bioadaptor Randomized Controlled Trial of DynamX Coronary Bioadaptor System

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced ...

Home February 16, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now